Gabapentin
Who holds supplier records for Gabapentin? 26 organisations hold a current record for Gabapentin: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 20 of them hold a valid EU Certificate of Suitability (21 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (13), China (7), Italy (3), Netherlands (1) and 2 other countries (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Gabapentin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/gabapentin
Reading the evidence
- 26 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 16 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (26)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Gabapentin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 26131, 31819 · latest filing Jul 2017
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPActive DMF 25825, 34315, 21401 · latest filing Jan 2020
- ANJAN DRUG PRIVATE LTDIndiaCEPActive DMF 22765 · latest filing May 2009
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 20122 · latest filing Dec 2006
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 19000 · latest filing Dec 2005
- FIS FABBRICA ITALIANA SINTETICI SPAItalyCEP Company GMP cert on recordActive DMF 14024 · latest filing Mar 1999
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 16060 · latest filing Jul 2002
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 18225 · latest filing Mar 2005
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 18171 · latest filing Mar 2005
- SARACA LABORATORIES LTDIndiaCEP Company GMP cert on recordActive DMF 30809 · latest filing Jul 2017
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 17543 · latest filing Jul 2004
- TAPI NL BVNetherlandsCEPActive DMF 12736 · latest filing Nov 1997
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaCEPActive DMF 41311, 43724 · latest filing Mar 2026
- Zhejiang Bamboo Pharmaceuticals Co.,LtdChinaCEPActive DMF 37761 · latest filing Jan 2023
- Zhejiang Chiral Medicine Chemicals Co., Ltd.ChinaCEPActive DMF 20826 · latest filing Aug 2007
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 36241 · latest filing Nov 2021
- ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTDChinaCEPActive DMF 37243 · latest filing Oct 2022
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 17063 · latest filing Dec 2003
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 37028 · latest filing Apr 2022
- Granules India LimitedIndia Company GMP cert on recordActive DMF 33536, 43660 · latest filing Mar 2026
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 16287, 17240 · latest filing Mar 2004
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 16151 · latest filing Sept 2002
- Zhejiang Excel Pharmaceutical Company., Ltd.ChinaActive DMF 26514 · latest filing Oct 2012
- ERREGIERRE SPAItalyCEP Company GMP cert on recordInactive DMF 17351, 15513 · latest filing Apr 2004
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordInactive DMF 36536 · latest filing Apr 2022
- MEDICHEM SASpainCEP Company GMP cert on recordInactive DMF 13178 · latest filing Sept 1998
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (21)
Certificates of Suitability on the EDQM register for Gabapentin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 30 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2022-228 - Rev 03 Gabapentin, Process-III | Jul 2026 | — |
| HIKAL LIMITED Bengaluru | IN | CEP 2013-055 - Rev 03 Gabapentin, Process II | Jul 2026 | Inspected Nov 2025 Switzerland |
| ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang | CN | CEP 2025-644 - Rev 00 Gabapentin | Jul 2026 | — |
| ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou | CN | CEP 2022-303 - Rev 01 Gabapentin, Site Yongtai Chiral | Mar 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2011-185 - Rev 03 Gabapentin | Oct 2025 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2013-167 - Rev 04 Gabapentin | Sept 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-167 - Rev 03 Gabapentin | Jul 2025 | — |
| ANJAN DRUG PRIVATE LIMITED Gummidipoondi | IN | CEP 2013-164 - Rev 02 Gabapentin | Jun 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2024-148 - Rev 01 Gabapentin, Process V | Jun 2025 | Inspected May 2026 Italy |
| ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing | CN | CEP 2023-027 - Rev 02 Gabapentin | Apr 2025 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2019-200 - Rev 01 Gabapentin, Alternative process | Apr 2025 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2019-343 - Rev 03 Gabapentin, Process II | Apr 2025 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LTD Ludhiana | IN | CEP 2022-188 - Rev 00 Gabapentin | Apr 2024 | — |
| ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou | CN | CEP 2011-258 - Rev 01 Gabapentin | Jan 2024 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2011-154 - Rev 03 Gabapentin | Sept 2023 | — |
| SARACA LABORATORIES LIMITED Gaddapotharam Village | IN | R1-CEP 2016-092 - Rev 00 Gabapentin | Apr 2022 | — |
| OLON S.P.A. Rodano | IT | R1-CEP 2011-344 - Rev 01 Gabapentin | Jun 2021 | — |
| F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore | IT | R1-CEP 2013-173 - Rev 00 Gabapentin | Aug 2019 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | R1-CEP 2012-210 - Rev 00 Gabapentin | Sept 2018 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Fengxin | CN | R1-CEP 2011-264 - Rev 00 Gabapentin | Oct 2017 | — |
| Medichem, S.A. Sant Joan Despí | ES | R1-CEP 2011-225 - Rev 00 Gabapentin | Jul 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Gabapentin are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- China · Inactive DMF 22015 · filed Sept 2008
- Jiangsu Nhwa Pharmaceutical Co., Ltd.China · Inactive DMF 20645 · filed May 2007
- SANDOZ INDUSTRIAL PRODUCTS SAInactive DMF 18489 · filed Jul 2005
- Italy · Inactive DMF 16342 · filed Dec 2002
Overview
Gabapentin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL940).
Chemical identity
- IUPAC name
- 2-[1-(aminomethyl)cyclohexyl]acetic acid
- Canonical SMILES
- C1CCC(CC1)(CC(=O)O)CN
- InChIKey
- UGJMXCAKCUNAIE-UHFFFAOYSA-N
- Synonyms
- CI-945, DM-1796, Gabapentin, Gabapentina, Gabapentine, GOE 3450, GOE-3450, Gralise, Neurontin, NSC-742194, NSC-759254, 1-(Aminomethyl)cyclohexaneacetic acid
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anti-epileptic Agent
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Gabapentin?
26 organisations hold an active US FDA Type II Drug Master File or a CEP for Gabapentin: Hetero Drugs Limited (India), Jiangxi Synergy Pharmaceutical Co., Ltd (China), ANJAN DRUG PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Divis Laboratories (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), HIKAL LTD (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 18 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Gabapentin Drug Master Files are active?
Hetero Drugs Limited (DMF 26131, 31819), Jiangxi Synergy Pharmaceutical Co., Ltd (DMF 25825, 34315), ANJAN DRUG PRIVATE LTD (DMF 22765), APITORIA PHARMA PRIVATE LTD (DMF 20122), Divis Laboratories (DMF 19000), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 14024), HIKAL LTD (DMF 16060) and MATRIX PHARMACORP PRIVATE LTD (DMF 18225) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Gabapentin records mean?
4 organisations have only inactive Type II DMFs for Gabapentin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Gabapentin have a European Certificate of Suitability?
Yes. 20 organisations hold a valid CEP for Gabapentin on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), HIKAL LIMITED Bengaluru (IN), ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang (CN), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN) and HETERO DRUGS LIMITED Hyderabad (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Gabapentin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Gabapentin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.